Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats
about
A review on chemical-induced inflammatory bowel disease models in rodentsThe TNBS-induced colitis animal model: An overviewKeratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.Potential protective effects of Clostridium butyricum on experimental gastric ulcers in miceOral administration of Clostridium butyricum CGMCC0313-1 inhibits β-lactoglobulin-induced intestinal anaphylaxis in a mouse model of food allergy.Spore-forming bacteria and their utilisation as probiotics.Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis.Using murine colitis models to analyze probiotics-host interactions.Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice.Effects of dietary supplementation of probiotic, Clostridium butyricum, on growth performance, immune response, intestinal barrier function, and digestive enzyme activity in broiler chickens challenged with Escherichia coli K88.Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells.A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats.The hepatoprotective effect of the probiotic Clostridium butyricum against carbon tetrachloride-induced acute liver damage in mice.Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis.Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis.
P2860
Q26827500-0DDED56D-5341-42BE-96DC-DC344C062786Q28077599-BDCB7A52-4EF3-4A1D-806B-98ABB450A2DAQ35033801-C7D574BF-5455-4A4D-9387-008FDA2903CEQ35049771-7DA0444C-6578-4CD9-9221-1DBCE9DA5899Q35865246-D232DFB9-CFF4-48B0-BC04-584B946C8334Q37661593-67C58AFF-8B8F-4B19-B909-C94CEA94FBC9Q37986269-A381D81B-7572-4C6E-AE58-5D77C46F6C3DQ38837157-B0F2529A-F6ED-4F9C-A501-B6B13C9C4BDEQ40084224-A69A98AB-7EA9-43A6-837A-D425A7DB36AFQ41203575-0083D468-14B5-44A4-A0BA-7FCC9EB634EEQ41837837-40707DCE-FDB3-4B15-A89C-D8F1855215F2Q43490293-769B9BEC-4552-4DB1-B99C-BEC1A8352357Q46462313-AA7BAF0C-9390-4950-8EA3-35733218EED8Q48340059-6CEED770-245C-4AF5-8EE9-D34AAF3F78D9Q49966509-DC4AC2CC-06A5-4B55-9D19-BD86044C3FA8Q50108353-BE5F1376-9D74-4A1F-8B5E-A24B2EDA9EADQ54936999-B6C42911-192D-446A-BD83-4E22A3063E69
P2860
Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic effects of Clostri ...... s induced by oxazolone in rats
@en
Therapeutic effects of Clostri ...... induced by oxazolone in rats.
@nl
type
label
Therapeutic effects of Clostri ...... s induced by oxazolone in rats
@en
Therapeutic effects of Clostri ...... induced by oxazolone in rats.
@nl
prefLabel
Therapeutic effects of Clostri ...... s induced by oxazolone in rats
@en
Therapeutic effects of Clostri ...... induced by oxazolone in rats.
@nl
P2093
P2860
P356
P1476
Therapeutic effects of Clostri ...... s induced by oxazolone in rats
@en
P2093
Hai-Qiang Zhang
Hai-Xia Zhang
Juan-Juan Zhang
Jun-Sheng Zhao
Tomas T Ding
Yun-Long Cui
P2860
P304
P356
10.3748/WJG.15.1821
P407
P577
2009-04-01T00:00:00Z